Incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) and Other Complications Following SARS-CoV-2. A Nationwide Population-based Study.

Status: Recruiting
Location: See location...
Study Type: Observational

Multisystem inflammatory syndrome in children (MIS-C) is a rare severe complication to SARS-CoV-2 infection in children. It has been reported to occur in approximately one of 3,000 to 4,000 unvaccinated children during the COVID-19 waves dominated by variant Alpha of SARS-CoV-2. However, the incidences following SARS-CoV-2 infection with variant delta and omicron, as well as among vaccinated children and adolescents with SARS-CoV-2 is yet unexplored. The investigators aim to estimate the incidence of MIS-C and in vaccinated and unvaccinated children and adolescents following variants delta and omicron, and other complications of SARS-CoV-2 including complication due to SARS-CoV-2 lock-down, based on a nationwide prospective population-based cohort study.

Participation Requirements
Sex: All
Maximum Age: 17
Healthy Volunteers: No

• MIS-C according to criteria devised by the World Health Organization and Centers for Disease Control and Prevention (CDC)

• Invasive bacterial infections and viral infections secondary to SARS-CoV-2 or as consequence of SARS-CoV-2 lock down

Other Locations
Copenhagen University Hospital Rigshospitalet
Contact Information
Ulrikka Nygaard
Time Frame
Start Date: July 15, 2021
Estimated Completion Date: December 31, 2024
Target number of participants: 150
Leads: Rigshospitalet, Denmark
Collaborators: Innovation Fund Denmark, Ministry of Education, Denmark

This content was sourced from